Challenging Cases in Viral Hepatitis

CCO HEP 2018 Annual Update Program Image
Led by Christian B. Ramers, MD, MPH, a panel of experts discusses their management approaches to challenging patient case scenarios, including a patient with decompensated cirrhosis and chronic HCV infection, a patient with suspected acute HCV infection and recent injection drug use, a DAA-experienced patient with genotype 1a HCV infection, and a patient with suppressed HBV infection and treated and cured HCV infection who has persistent liver enzyme elevations.
Norah Terrault, MD, MPH
Program Director
Paul Y. Kwo, MD
Paul Martin, MD
Christian Ramers Headshot
Christian B. Ramers, MD, MPH
Released: July 6, 2018 Expiration: No longer available for credit

Related Content

Downloadable slides from CCO expert, Dr. Alain H. Litwin, on integrating HCV and HIV prevention and care strategies into addiction care settings

Alain H. Litwin, MD Released: September 18, 2020

Dr. Stefan Zeuzem discusses new viral hepatitis data reported at the 2020 Digital International Liver Congress, in the CCO Infectious Disease podcast

Stefan Zeuzem, MD Released: September 14, 2020

Expert selections of the most important viral hepatitis data from EASL 2020, including HCV elimination and HCV and HBV treatment, provided by CCO

Stefan Zeuzem, MD Released: September 8, 2020

Downloadable PDF resource from CCO on opioid use disorder treatment essentials for hepatologists and ID specialists managing HCV and/or HIV infection

Jenna Butner, MD Released: May 7, 2020
Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Educational grants provided by
AbbVie
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue